| scholarly article | Q13442814 |
| P2093 | author name string | Y Kojima | |
| J H Griffin | |||
| M J Heeb | |||
| T M Hackeng | |||
| P2860 | cites work | Protein S binds to and inhibits factor Xa | Q24310133 |
| Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C | Q24563608 | ||
| General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids | Q24612820 | ||
| Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study | Q28237067 | ||
| The mechanism of inactivation of human factor V and human factor Va by activated protein C | Q28242588 | ||
| Loss of prothrombin and of factor Xa-factor Va interactions upon inactivation of factor Va by activated protein C | Q28268488 | ||
| The role of phospholipids and factor Va in the prothrombinase complex | Q28281889 | ||
| The binding of activated protein C to factors V and Va | Q28304170 | ||
| Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism | Q28305220 | ||
| Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C | Q28631087 | ||
| Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C. | Q36278184 | ||
| Prothrombinase complex assembly on the platelet surface is mediated through the 74,000-dalton component of factor Va. | Q37609598 | ||
| The role of factor V in the assembly of the prothrombinase complex | Q40312885 | ||
| Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. | Q40578276 | ||
| A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va. | Q46204483 | ||
| Identification of a sequence of human activated protein C (residues 390-404) essential for its anticoagulant activity | Q46246763 | ||
| Identification of the binding site for activated protein C on the light chain of factors V and VIII. | Q46645892 | ||
| Proposed structure of the A domains of factor VIII by homology modelling. | Q50758954 | ||
| A monoclonal antibody which inhibits the factor Va:factor Xa interaction. | Q52709114 | ||
| Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia. | Q54202843 | ||
| Resistance to activated protein C as a basis for venous thrombosis. | Q54214042 | ||
| Regulation of activated protein C by factor Xa | Q67907142 | ||
| Proteolysis of factor Va by factor Xa and activated protein C | Q69139671 | ||
| Kinetics of inactivation of membrane-bound factor Va by activated protein C. Protein S modulates factor Xa protection | Q70061814 | ||
| Anticoagulant protein C pathway defective in majority of thrombophilic patients | Q70482893 | ||
| Inactivation of human coagulation factor V by activated protein C | Q71243238 | ||
| Localization of factor IXa and factor VIIIa interactive sites | Q71824227 | ||
| Factor VIIIa A2 subunit residues 558-565 represent a factor IXa interactive site | Q72108212 | ||
| Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa | Q72135903 | ||
| Contribution of the heavy and light chains of factor Va to the interaction with factor Xa | Q72520628 | ||
| Characterization of the molecular defect in factor VR506Q | Q72591739 | ||
| Activated protein C resistance caused by Arg506Gln mutation in factor Va | Q72677734 | ||
| Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V | Q72681302 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 1883-1889 | |
| P577 | publication date | 1996-09-01 | |
| P1433 | published in | Protein Science | Q7251445 |
| P1476 | title | Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va. | |
| P478 | volume | 5 |
| Q36122255 | A bipartite autoinhibitory region within the B-domain suppresses function in factor V |
| Q44435259 | Amino Acids Glu323, Tyr324, Glu330, and Val331 of Factor Va Heavy Chain Are Essential for Expression of Cofactor Activity |
| Q44798012 | Binding site for blood coagulation factor Xa involving residues 311-325 in factor Va. |
| Q92129559 | Blood coagulation factor Va's key interactive residues and regions for prothrombinase assembly and prothrombin binding |
| Q33883315 | C-terminal residues 621-635 of protein S are essential for binding to factor Va. |
| Q53548163 | Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage site. |
| Q42287626 | Contribution of amino acid region 334-335 from factor Va heavy chain to the catalytic efficiency of prothrombinase |
| Q44183079 | Defining the factor Xa-binding site on factor Va by site-directed glycosylation |
| Q84059905 | Down regulation of prothrombinase by activated protein C during prothrombin activation |
| Q53602924 | Effects of factor Xa and protein S on the individual activated protein C-mediated cleavages of coagulation factor Va. |
| Q41936652 | Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation. |
| Q44683596 | Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679. |
| Q46162373 | Factor Va residues 311-325 represent an activated protein C binding region |
| Q52874413 | Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance. |
| Q53473754 | Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin. |
| Q54102151 | Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation. |
| Q77195347 | Inhibition of prothrombinase by human secretory phospholipase A2 involves binding to factor Xa |
| Q38269759 | Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C |
| Q40422254 | Mapping of the factor Xa binding site on factor Va by site-directed mutagenesis |
| Q41142483 | Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala-activated protein C mediated by factor Va |
| Q55454996 | Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation. |
| Q26999113 | Protein C anticoagulant and cytoprotective pathways |
| Q37233988 | Restoring the procofactor state of factor Va-like variants by complementation with B-domain peptides |
| Q43579841 | Secondary substrate-binding exosite in the serine protease domain of activated protein C important for cleavage at Arg-506 but not at Arg-306 in factor Va. |
| Q42026523 | Structural investigation of the A domains of human blood coagulation factor V by molecular modeling |
| Q50866405 | The SHBG-like region of protein S is crucial for factor V-dependent APC-cofactor function. |
| Q36156027 | The anticoagulant protein C pathway |
Search more.